Published in PLoS One on June 25, 2008
Recipient survival and graft survival are not diminished by simultaneous liver-kidney transplantation: an analysis of the united network for organ sharing database. Liver Transpl (2012) 1.54
Impact of broader sharing on the transport time for deceased donor livers. Liver Transpl (2014) 1.41
Salvage liver transplantation in the treatment of hepatocellular carcinoma: a meta-analysis. World J Gastroenterol (2012) 0.90
Impact of human leukocyte antigen mismatching on outcomes of liver transplantation: a meta-analysis. World J Gastroenterol (2010) 0.84
Uterus transplantation: current progress and future prospects. Int J Womens Health (2016) 0.81
Hypoxia-inducible factors as molecular targets for liver diseases. J Mol Med (Berl) (2016) 0.79
The mitochondria-targeted anti-oxidant MitoQ decreases ischemia-reperfusion injury in a murine syngeneic heart transplant model. J Heart Lung Transplant (2015) 0.79
Sequential vs simultaneous revascularization in patients undergoing liver transplantation: A meta-analysis. World J Gastroenterol (2015) 0.77
Functional evaluation of rat hearts transplanted after preservation in a high-pressure gaseous mixture of carbon monoxide and oxygen. Sci Rep (2016) 0.77
Liver grafts from selected older donors do not have significantly more ischaemia reperfusion injury. HPB (Oxford) (2011) 0.77
Early cytokine signatures of ischemia/reperfusion injury in human orthotopic liver transplantation. JCI Insight (2016) 0.75
Effects of Donor Age and Cold Ischemia on Liver Transplantation Outcomes According to the Severity of Recipient Status. Dig Dis Sci (2016) 0.75
Donor gluconate rescues livers from uncontrolled donation after cardiac death. Surgery (2015) 0.75
Amifostine enhances the antioxidant and hepatoprotective effects of UW and HTK preservation solutions. World J Gastroenterol (2014) 0.75
Geographic Variation in Cold Ischemia Time: Kidney vs. Liver Transplantation in the United States, 2003-2011. Transplant Direct (2015) 0.75
Moesin functionality in hypothermic liver preservation injury. Cryobiology (2014) 0.75
Uterus Transplant: Does It Have Legs? J Obstet Gynaecol India (2017) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
A method for assessing the quality of a randomized control trial. Control Clin Trials (1981) 6.63
Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99
Kidney preservation for transportation. Initial perfusion and 30 hours' ice storage. Lancet (1969) 3.67
Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology (1994) 2.73
Risk factors for primary dysfunction after liver transplantation--a multivariate analysis. Transplantation (1993) 2.20
Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation (1992) 2.03
Analysis of donor criteria for the prediction of outcome in clinical liver transplantation. Transplant Proc (1987) 1.90
Effect of cold ischemia time on the early outcome of human hepatic allografts preserved with UW solution. Transplantation (1991) 1.71
Effect of extended cold ischaemia with UW solution on graft function after liver transplantation. Lancet (1992) 1.68
72-hour preservation of the canine pancreas. Transplantation (1987) 1.55
The use of marginal donors for liver transplantation. A retrospective study of 365 liver donors. Transplantation (1992) 1.41
Evidence for the detrimental role of proteolysis during liver preservation in humans. Gastroenterology (1995) 1.40
Preoperative and intraoperative predictors of postoperative morbidity, poor graft function, and early rejection in 190 patients undergoing liver transplantation. Arch Surg (2001) 1.20
A methodological framework for optimally reorganizing liver transplant regions. Med Decis Making (2005) 1.20
MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes. JAMA (2004) 1.17
Predictive factors of early postoperative graft function in human liver transplantation. Hepatology (1994) 1.16
Influence of donor and recipient gender on the outcome of liver transplantation. Transplantation (1996) 1.05
Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Transplantation (1998) 1.04
Mechanism of hepatic ischemia/reperfusion injury and protection against reperfusion injury. Transplant Proc (2002) 1.00
Personal experience with the procurement of 132 liver allografts. Transpl Int (1989) 0.98
A comparison of UW with Eurocollins preservation solution in liver transplantation. Transplantation (1990) 0.96
Influence of cold ischemia time and graft transport distance on postoperative outcome in human liver transplantation. Surg Today (2002) 0.95
Comparison of UW solution and Euro-Collins solutions for cold preservation of human liver grafts. Transplantation (1990) 0.93
The use of older donor livers for hepatic transplantation. Transplantation (1990) 0.92
University of Wisconsin versus histidine-tryptophan-ketoglutarate for tissue preservation in live-donor liver transplantation. Exp Clin Transplant (2006) 0.87
Liver procurement without in situ portal perfusion. A safe procedure for more flexible multiple organ harvesting. Transplantation (1994) 0.86
Experimental evaluation of Celsior, a new heart preservation solution. Eur J Cardiothorac Surg (1994) 0.85
Contribution of true cold and rewarming ischemia times to factors determining outcome after orthotopic liver transplantation. Liver Transpl Surg (1995) 0.85
Donor-specific factors predict graft function following liver transplantation. Transplant Proc (1990) 0.85
Deleterious effect of extended cold ischemia time on the posttransplant outcome of aged livers. Transplant Proc (1995) 0.84
Poor initial graft function after orthotopic liver transplantation: can it be predicted and does it affect outcome? An analysis of 125 adult primary transplantations. Clin Transplant (1997) 0.83
Impact of donor factors and preservation on function and survival after liver transplantation. Transplant Proc (1993) 0.81
A multicenter pilot prospective study comparing Celsior and University of Wisconsin preserving solutions for use in liver transplantation. Liver Transpl (2003) 0.81
Mechanisms of preservation and ischemic/reperfusion injury in liver transplantation. Transplant Proc (2002) 0.80
An analysis of pretransplantation variables associated with long-term allograft outcome in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. Transplantation (1999) 0.80
Assessment of prognosis in transplant candidates by use of the Pugh-MEGX score. Transplant Proc (1993) 0.80
Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation. Transplant Proc (1995) 0.80
The impact of extended preservation on clinical liver transplantation. Transplantation (1990) 0.80
Rapid en bloc technique for pancreas-liver procurement. Improved early liver function. Transplantation (1996) 0.80
Ringer's lactate vs serum albumin as a flush solution for UW preserved liver grafts: results of a prospective randomized study. Transplant Proc (1991) 0.79
Factors relevant to the development of primary dysfunction in liver allografts. Transplant Proc (1995) 0.79
A comparative prospective study of two available solutions for kidney and liver preservation. Transplantation (2004) 0.79
Early predictive markers of irreversible graft dysfunction after liver transplantation. Transplant Proc (1994) 0.78
Randomized clinical study comparing UW and Celsior solution in liver preservation for transplantation: preliminary results. Transplant Proc (2001) 0.78
Donor MEGX test fails to predict graft function after orthotopic liver transplant. Transplant Proc (1997) 0.77
Study of liver preservation: efficacy of a combined method using the UW solution. Transplant Proc (1992) 0.77
A prospective randomized trial between Euro-Collins and University of Wisconsin solutions as the initial flush in hepatic allograft procurement. Transplantation (1992) 0.77
Limits of the MEGX test in the selection of liver grafts for transplantation. Transplant Proc (1993) 0.77
Evaluation of quantitative liver function tests in liver donors. Transplant Proc (1987) 0.77
Prediction of graft dysfunction by analysis of liver biopsies after cold storage. Transpl Int (1996) 0.77
Cold ischemia time vs outcome of human liver transplantation using UW solution. Transplant Proc (1991) 0.77
Prospective multivariate analysis of donor monoethylglycine xylidide (MEGX) testing in liver transplantation. Transplantation Society of Michigan Scientific Studies Committee. Clin Transplant (1998) 0.77
Influence of ischemia and surgery times on development of primary dysfunction liver transplant in patients. Transplant Proc (2003) 0.77
Laboratory test scores to aid identification of primary nonfunction of liver transplants. Clin Chem (1995) 0.76
Preliminary results of a clinical randomized study comparing Celsior and HTK solutions in liver preservation for transplantation. Transplant Proc (2005) 0.76
The use of the University of Wisconsin (UW) and Euro-Collins (EC) solutions either alone or in a combined method. Transpl Int (1992) 0.76
A biodegradable and biocompatible gecko-inspired tissue adhesive. Proc Natl Acad Sci U S A (2008) 2.58
A clinically based discrete-event simulation of end-stage liver disease and the organ allocation process. Med Decis Making (2005) 1.45
The changing burden of hepatitis C virus infection in the United States: model-based predictions. Ann Intern Med (2014) 1.33
Tissue-engineered small intestine and stomach form from autologous tissue in a preclinical large animal model. J Surg Res (2009) 1.30
A methodological framework for optimally reorganizing liver transplant regions. Med Decis Making (2005) 1.20
Markov decision processes: a tool for sequential decision making under uncertainty. Med Decis Making (2009) 1.09
Increasing the efficiency of Monte Carlo cohort simulations with variance reduction techniques. Med Decis Making (2006) 0.95
Manufacture of porous polymer nerve conduits by a novel low-pressure injection molding process. Biomaterials (2003) 0.93
Simulation and critical care modeling. Curr Opin Crit Care (2004) 0.92
Use of dynamic microsimulation to predict disease progression in patients with pneumonia-related sepsis. Crit Care (2007) 0.84
Comparative effectiveness of guidelines for the management of hyperlipidemia and hypertension for type 2 diabetes patients. PLoS One (2011) 0.75